Allison May
Saint Louis University
22 Papers
37 Citations
Allison May is an academic researcher from Saint Louis University. The author has contributed to research in topics: Cancer & Renal cell carcinoma. The author has an hindex of 4, co-authored 17 publications.
Chat about Author
Papers
Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database
TL;DR: Reviewing the United States National Cancer Database from 2004 to 2015 and analyzing survival outcomes of invasive non-urachal adenocarcinoma based on treatment modality found survival benefits in patients without metastatic disease are seen only in those patients undergoing definitive surgery.
24
Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
Coleman McFerrin,Facundo Davaro,Allison May,Syed Johar Raza,Sameer Siddiqui,Zachary Hamilton +5 more
TL;DR: The increasing use of perioperative chemotherapy noted in prior studies has continued through 2015, and neoadjuvant chemotherapy appears to drive this increase while adjuvant chemotherapy utilization remains unchanged.
The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity
W. Storck,Allison May,Thomas C. Westbrook,Zhijian Duan,Colm Morrissey,Joel A. Yates,Joshi J. Alumkal +6 more
TL;DR: The role of AR pathway loss and activation of a neuronal differentiation program as key contributors to t-NEPC lineage plasticity are discussed and new epigenetic therapeutic strategies to reverse lineage plasticITY are discussed.
15
Current Trends in Partial Nephrectomy After Guideline Release: Health Disparity for Small Renal Mass
Allison May,Anirudh Guduru,Joshua Fernelius,Syed Johar Raza,Facundo Davaro,Sameer Siddiqui,Zachary Hamilton +6 more
- 01 Jan 2019
TL;DR: Although use of PN in surgically appropriate patients for cT1a renal masses has increased over time, 30% of patients underwent RN in 2015, up from 40.2% in 2004 to 71.3% in 2015.
10
Trends in the treatment of clinical T1 renal cell carcinoma for octogenarians: Analysis of the National Cancer Database
TL;DR: For octogenarians with stage 1 renal cell carcinoma, minimally invasive treatments are increasingly utilized, while RN is decreasing, and these findings remain encouraging for appropriate treatment of localized disease in patients with advanced age.
10